Revenue rose by 20% annually to Rs 1,284 crore between FY20 and FY22, while net profit dropped by 16% to Rs 76.4 crore. Revenue growth was driven by the acquisition of SGS. This however resulted in a sharp drop in the operating margin before depreciation and amortisation (EBITDA margin) to 11.3% in FY22 from 16.8% in FY20.
Mukul Agrawal reshapes Rs 6,500-crore portfolio in Q3: Two new stocks, one exit. Do you own?
Mukul Agrawal has updated his Rs 6,500-crore stock portfolio. He added Hindustan Construction and Sudeep Pharma. Agrawal reduced his stake in Monolithisch and likely exited